Le Lézard
Classified in: Health
Subjects: PDT, MAT

National CBD Day Ignites Huge Event for Industry Leader, FAB CBD


Celebrating CBD in a very big way, FAB CBD offers 35% off site wide, for two days only.

MILWAUKEE, Aug. 8, 2022 /PRNewswire/ -- It is National CBD Day, and the folks at FAB CBD are ready for it. Included in the celebration is a deep discount of 35% on all products, including two new items on their top-quality roster. But first, a little bit about the day that's being observed.

Industry leader FAB CBD celebrates National CBD Day with 35% off storewide for two days only.

The federal government defined hemp in 2018 as a legal plant that is distinct from marijuana, due to the incredibly low levels of THC in it (less than .03%). Therefore, hemp-based products like CBD oil no longer fell under national anti-drug laws. Since that time, CBD has developed into a highly popular and well-known ingredient in oils, creams, gummies, capsules, and more. FAB CBD is a major player in the industry and loves to have a big event in celebration of the hemp compound that they built their company around.

Shop the CBD Day Sale? 35% Off Storewide.

The new Complete Cannabinoidtm Softgel is a great reason to shop this sale. A few things set this full spectrum capsule apart from what other brands are doing. First, it contains equal parts CBD, CBG, CBN, and CBC, which is almost unheard of in the current CBD market. Second, it is made with cassava root rather than gelatin, making the softgel accessible to vegetarians and vegans in addition to the rest of the population. Customers are raving about how easy the softgels are to swallow or to carry with them on the go, and they love having a taste-free option in their CBD regimen.

Try New Complete Cannabinoidtm Softgels for 35% off

Another new product in the FAB CBD store is an unflavored CBD+CBG Oil. This popular and potent 2400mg oil was previously only available in mint and citrus but can now be experienced with the natural flavor of hemp. An expertly balanced 1:1 ratio of CBD and CBG shines in this robust full spectrum blend, establishing a gold standard for tinctures in the CBD industry.

Shop 35% off  natural flavor CBD+CBG oil.

Effective today, customers can shop all products for up to 35% off storewide. The sale lasts until August 10th, using the code: CBDDAY.

Shop The Sale By Going To: https://fabcbd.com/pages/cbd-day

SOURCE FAB CBD


These press releases may also interest you

at 07:05
Executive War College to Address, Clinical Laboratories' and Genetic Testing Firms' Perfect Storm, involving FDA's Proposed LDT Rule, Payers Requiring Z-Codes on Genetic Test Claims, and Revisions to CLIA Regulations
Three major challenges poised to confront the nation's clinical laboratories, genetic test companies, and anatomic pathology laboratories will be major topics when a top-flight roster of lab experts, innovators, and lab leaders gather in New Orleans...

at 07:05
Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1
Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that second quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday,...

at 07:04
Health Canada Approves KEYTRUDA® as a first-line treatment for adult patients with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma in combination with fluoropyrimidine- and platinum-containing chemotherapy
Merck , known as MSD outside the United States and Canada, announced that Health Canada has granted approval of  KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in combination with fluoropyrimidine- and platinum-containing-chemotherapy, for the...

at 07:00
GLOBE LIFE INC. ANNOUNCES FIRST QUARTER 2024 EARNINGS RELEASE AND CONFERENCE CALL
Globe Life Inc. will release First Quarter 2024 earnings after the market closes on Monday, April 22, 2024.  At that time, a copy of the Company's First Quarter 2024 earnings press release and any other financial and statistical information about...

at 07:00
GenFleet Therapeutics Announces FDA's Clinical Trial Approval for GFH925 (KRAS G12C Inhibitor) Monotherapy in Phase III Registrational Study Treating Metastatic Colorectal Cancer
GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Administration (FDA) has granted the clinical trial approval for GFH925 (KRAS G12C inhibitor) in a...

at 07:00
Drug-Free Pain Relief Comes in the Form of Red Laser Therapy
César A. Lara, MD, introduces a groundbreaking solution for pain relief in the Tampa Bay area. Red Laser Therapy leverages the power of medical-grade red laser light to effectively address various types of pain, providing patients with a noninvasive...

More news about Health...


News published on and distributed by: